FDA feedback confirms Adial's proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging ...

Health care providers can now administer Sublocade subcutaneously into the thigh, buttock, or the back of the upper arm, in addition to the abdomen.

Indian authorities banned the manufacturing and export of Tapentadol, Carisoprodol combination drugs, two highly addictive ...

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

The case emerged following an investigative report by BBC, which uncovered the sale of Aveo-branded combination medicines in ...

India’s weak drug regulation is spreading a problem from Africa to America. Reputational damage can be big India’s drug regulators have been caught napping once again. Various pills made by ...

Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...

Africa, Bright Simons, has provided a detailed breakdown of the opioid crisis uncovered in the latest BBC Africa Eye ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.

Indivior PLC (Nasdaq/LSE: INDV), a global leader in addiction treatment, today announced that the U.S. Food and Drug Administration (FDA) has approved label changes for SUBLOCADE® including a rapid ...

The Indian government has taken decisive action against Aveo Pharmaceuticals Ltd (Aveo) after a BBC investigation alleged that the company was illegally exporting unapproved opioid combinations to ...